Please assess the completion status of the following clinical trial:

Trial Title: Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* \>18 years old,~* ESLD MELD \<25,~* No recent infection,~* no hepatic decompensation,~* no history of HIV,~* weight \> 110 lbs,~* platelets \> 50,000,~* HGB \>10,~* no prior organ transplant~Exclusion Criteria:~* Patients ineligible for liver transplant,~* patients who do not understand why the study procedures are being conducted,~* subjects who do not meet all inclusion criteria.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 89 Years
- Healthy Volunteers: f

Study Arms:
- Leaukapheresis of End Stage Liver Disease Patients (Type: OTHER): Leukapheresis. All subjects will receive the same treatment arm.

Based on this trial design, predict the completion outcome and termination type (if applicable).